Stock Price
1.09
Daily Change
-0.05 -3.96%
Monthly
4.31%
Yearly
-62.67%
Q1 Forecast
1.19

Avita Medical reported AUD12.22M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Celltrion KRW 29.65B 799.42B Jun/2025
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Cochlear AUD 275.7M 107.4M Jun/2025
CSL USD 2.16B 633M Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Mayne Pharma AUD 110.07M 838K Jun/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Nanosonics AUD 161.29M 156.45M Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pacific Edge NZD 29.26M 8.79M Jun/2024
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
Polynovo AUD 45.91M 330K Jun/2024
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Ramsay Health Care AUD 784.4M 443.3M Jun/2025
ResMed USD 1.42B 33.22M Dec/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Telix Pharmaceuticals AUD 710.35M 587.11M Dec/2024
Tilray USD 264.83M 43.16M Jun/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025